NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
31/07/2026
Voltar para busca
Dado oficial do USPTO
RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH
ST13
US500000079155747Classe
36, 41
Pedido
79155747
Registro
5075539
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
31/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
36, 41
Data de depósito
29/08/2014
Data de registro
08/11/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/07/2026
Última transação
31/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
CH-8200 Schaffhausen, CH
Examinador
BIBB, SCOTT
Localização atual
Historical data usage
Titulares e representantes
Titulares
Rising Tide Foundation for Clinical Cancer Research
R. F. (pessoa física)
Representantes
Amy Cohen Heller Law Office of Amy Cohen Heller, LLC
Classificação técnica
Classes Nice
Classe 36Classe 41
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 36
Provision of funding for the social fieldproviding financial assistance in the nature of working capital to social programs and activities for the physically and mentally challengedthe chronically ill and the elderly; Provision of funding for the training fieldproviding financial assistance to education institutions by providing scholarship grants; Provision of funding for the health fieldproviding financial assistance in the nature of funding research awards for innovative clinical cancer research and scientific studies as well as institutions conducting clinical scientific cancer research; Provision of funding in the nature of working capital for inventorsresearch institutes and universities with the purpose of furthering clinical cancer research
Classe 41
Preparationhosting and conducting of colloquiumsseminars and training workshops in the field of clinical cancer and scientific research; organization and preparation of conferencescongressesseminars and symposiums in the field of clinical cancer and scientific research
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
71AG
REGISTERED-SEC.71 ACCEPTED
31/07/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27/07/2026
ES71
TEAS SECTION 71 RECEIVED
13/04/2026
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
08/11/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
11/04/2024
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09/01/2024
71AG
REGISTERED-SEC.71 ACCEPTED
09/01/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
19/12/2023
ES71
TEAS SECTION 71 RECEIVED
28/04/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/11/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
23/06/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/06/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/05/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/05/2017
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
21/02/2017
XXCR
GENERIC MADRID TRANSACTION CREATED
21/02/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/02/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
08/11/2016
CHPB
POST PUBLICATION AMENDMENT - ENTERED
03/10/2016
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
20/09/2016
APET
ASSIGNED TO PETITION STAFF
14/09/2016
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
31/08/2016
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/07/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/04/2016
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27/04/2016
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
05/04/2016
PUBO
PUBLISHED FOR OPPOSITION
08/03/2016
GPNX
NOTIFICATION PROCESSED BY IB
04/03/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/02/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/02/2016
NPUB
NOTICE OF PUBLICATION
17/02/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
29/01/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/01/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/12/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/12/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/12/2015
CNRT
NON-FINAL ACTION MAILED
10/08/2015
CNRT
NON-FINAL ACTION WRITTEN
10/08/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/06/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/06/2015
ALIE
ASSIGNED TO LIE
25/06/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/06/2015
RFNT
REFUSAL PROCESSED BY IB
08/01/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/12/2014
RFRR
REFUSAL PROCESSED BY MPU
22/12/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/12/2014
CNRT
NON-FINAL ACTION WRITTEN
20/12/2014
DOCK
ASSIGNED TO EXAMINER
12/12/2014
MAFR
APPLICATION FILING RECEIPT MAILED
06/12/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/12/2014
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
27/11/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RISING TIDE FOUNDATION FOR CLINICAL CANCER RESEARCH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.